Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$25.86 - $46.71 $3.29 Million - $5.94 Million
127,166 Added 153.38%
210,074 $9.76 Million
Q1 2023

May 15, 2023

BUY
$26.05 - $32.31 $1.4 Million - $1.73 Million
53,615 Added 183.03%
82,908 $2.38 Million
Q4 2022

Feb 14, 2023

BUY
$19.77 - $42.23 $357,322 - $763,265
18,074 Added 161.1%
29,293 $913,000
Q3 2022

Mar 03, 2023

SELL
$14.97 - $22.65 $270,567 - $409,376
-18,074 Reduced 61.7%
11,219 $227,000
Q3 2022

Nov 14, 2022

BUY
$14.97 - $22.65 $9,760 - $14,767
652 Added 6.17%
11,219 $228,000
Q2 2022

Aug 15, 2022

BUY
$13.19 - $22.1 $139,378 - $233,530
10,567 New
10,567 $164,000

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.